author-photo

Dima El-Sharkawi

University College London Hospitals NHS Foundation Trust

25

Papers

146

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)

2020 Journal of Plastic Reconstructive and Aesthetic Surgery
Show All
- Source
- Cite
- Save
Citations (1)
Haematological Cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.

2020 British Journal of Haematology
- Dima El-Sharkawi
- Sunil Iyengar
Show All
- Source
- Cite
- Save
Citations (16)
Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms.

2020 Radiographics
Show All
- Source
- Cite
- Save
Citations (25)
REAL WORLD EXPERIENCE IN THE MANAGEMENT OF WALDENSTRÖMʼS MACROGLOBULINAEMIA FROM ANALYSIS OF THE RORY MORRISON REGISTRY: PF621

2019
Show All
- Source
- Cite
- Save
Citations (0)
Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment

2018 Haematologica
Show All
- Source
- Cite
- Save
Citations (4)
Encouraging Outcomes for Patients with Multiple Myeloma Treated in Early Phase Clinical Trials: A Single Centre and Meta-Analysis

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Dose-Escalation (DE) Study with Expansion Evaluating Safety, Pharmacokinetics and Efficacy of the Novel, Balanced PI3K/mTOR Inhibitor PQR309 in Patients with Relapsed or Refractory Lymphoma

2016 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (56)